UBS: Europe is not the US when it comes to life sciences

While US life sciences markets cool, Europe’s policy support, talent inflows and stable demand create a resilient investment landscape, says Olafur Margeirsson, head of real estate, research and strategy, EMEA ex-DACH, at UBS.